Portfolio Design Labs’s AbbVie ABBV Stock Holding History

Portfolio Design Labs’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Buy	11,344 +258	+2%	+$55.5K	0.47%	45
2026 Q1	$2.41M	Sell	11,086 -1,082	-9%	-$240K	0.43%	40
2025 Q4	$2.78M	Buy	12,168 +493	+4%	+$112K	0.46%	40
2025 Q3	$2.7M	Buy	11,675 +8,598	+279%	+$1.75M	0.46%	40
2025 Q2	$571K	Sell	3,077 -4,734	-61%	-$880K	0.11%	101
2025 Q1	$1.64M	Sell	7,811 -12,843	-62%	-$2.5M	0.34%	81
2024 Q4	$3.67M	Buy	20,654 +4,404	+27%	+$810K	0.75%	30
2024 Q3	$3.21M	Sell	16,250 -1,624	-9%	-$303K	0.9%	27
2024 Q2	$3.07M	Buy	17,874 +2,632	+17%	+$436K	0.95%	36
2024 Q1	$2.78M	Buy	15,242 +9,494	+165%	+$1.64M	0.93%	39
2023 Q4	$891K	Buy	+5,748	New	+$838K	0.34%	68

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Portfolio Design Labs's ABBV Position: Q2 2026 in Review

Portfolio Design Labs increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $55.5K and bringing the position to 11,344 shares worth $2.85M. The position accounts for 0.47% of the portfolio, ranked #45.

Portfolio Design Labs first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.67M in Q4 2024. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Portfolio Design Labs held 11,344 shares of AbbVie worth $2.85M as of Q2 2026.
Portfolio Design Labs bought 258 AbbVie shares in Q2 2026, an estimated $55.5K.
AbbVie made up 0.47% of Portfolio Design Labs's portfolio in Q2 2026, its #45 holding.
Portfolio Design Labs first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Portfolio Design Labs's AbbVie position peaked at $3.67M in Q4 2024.
4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.